Ballentine Partners »

Crinetics Pharmaceuticals In shares owned by Ballentine Partners

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Ballentine Partners from 13F filings

Historical chart of Ballentine Partners investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Ballentine Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $459k 12k 37.42

More positions owned by Ballentine Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Glb Infrastr Etf (IGF)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Ballentine Partners

Top funds holding Crinetics Pharmaceuticals In

FMR
BlackRock
Farallon Capital Management
Wellington Management Company
Driehaus Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Henderson Group
EcoR1 Capital
Bellevue Group
Geode Capital Management
State Street Corporation
Baker Bros. Advisors
Siren
Pictet Asset Management Holding SA

View all funds holding Crinetics Pharmaceuticals In